RNA Targeted Small Molecules Market: High-Potential Segment Driven by RNA Biology Advances, AI-Assisted Drug Discovery, and Unmet Needs in Cancer and Genetic Diseases
The RNA Targeted Small Molecules Market is a rapidly emerging segment in drug development, driven by advances in RNA biology, AI-assisted drug discovery, and unmet therapeutic needs in cancer, neurological, and genetic diseases. Estimates vary by scope: one focused “RNA-Targeted Small Molecules” analysis valued the market at about USD 2.24 billion in 2023, projecting growth to...
0 Comments 0 Shares 64 Views 0 Reviews